![Symphony Robotics licenses expertise to deal with mind tumors Symphony Robotics licenses expertise to deal with mind tumors](https://www.therobotreport.com/wp-content/uploads/2025/02/symphonyrobotics-featured.jpg)
Symphony Robotics’ patent-pending expertise combines micro-robotic arms, real-time pc imaginative and prescient, and AI. | Supply: Symphony Robotics
Symphony Robotics introduced Tuesday that it licensed micro-robotic arm expertise from Case Western Reserve College (CWRU).
Cleveland-based Symphony Robotics licensed CWRU’s novel, MRI-guided, magnetically actuated robotic platform. The expertise navigates non-linear trajectories, enabling exact, micro-invasive surgical procedures with real-time steering.
The firm plans to advance the expertise that mixes micro-robotic arms, real-time pc imaginative and prescient, and state-of-the-art AI. Its preliminary focus facilities round offering neurosurgeons with enhanced capabilities for advanced microsurgical procedures. They aim mind most cancers — notably glioblastoma multiforme (GBM) — and epilepsy.
In the end, Symphony says it hopes to cut back incision and craniotomy dimension to lower than 4mm. This is able to mark a tenfold discount in comparison with present scientific norms. The expertise might allow prolonged, exact entry to deep-seated lesions whereas defending the encircling tissue.
Register in the present day to avoid wasting 40% on convention passes!
The corporate constructed its ultra-maneuverable micro-robotic expertise to leverage MRI capabilities and allow real-time steering. Its product stays investigational. This expertise is predicated on two proprietary developments: leveraging the magnetic capabilities of MRI programs for non-linear navigation of the micro robotic arms and enabling real-time steering with MRI’s excessive decision imaging.
Symphony Robotics says it’s making ready for nationwide testing in collaboration with main companion hospitals. This product just isn’t out there for scientific use and has not been cleared to be used by the US FDA.
Symphony targets GBM
GBM is among the many most aggressive and difficult mind cancers to deal with, the corporate says. Present surgical strategies, akin to craniotomies, are extremely invasive, requiring massive cranium openings and posing vital dangers. These embody trauma to wholesome mind tissue and delays in follow-up remedies akin to radiation, chemotherapy, or drug supply.
Different strategies akin to laser ablation solely help a restricted and partial remedy possibility. Symphony Robotics’ versatile, non-linear micro robotic arm goals to allow prolonged and exact entry to deep-seated lesions whereas defending surrounding eloquent tissue. This has the potential to enhance outcomes and high quality of life for GBM sufferers.
“Our expertise will introduce unprecedented developments in neurosurgery,” mentioned Mordechai (Moty) Avisar, Symphony Robotics founder and CEO. “The potential to boost surgical precision and enhance affected person outcomes is actually groundbreaking. Neurosurgeons will be capable to carry out extremely focused procedures on deep-seated pathologies by means of considerably smaller surgical openings—all the way down to the micro degree—whereas navigating advanced, geometrically dispersed pathologies with larger security and accuracy.”
Editor’s Word: This text was syndicated from The Robotic Report’s sibling website MassDevice.